Brett Hale Sells 24,188 Shares of Hyperfine (NASDAQ:HYPR) Stock

Hyperfine, Inc. (NASDAQ:HYPR) CFO Brett Hale sold 24,188 shares of Hyperfine stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total value of $29,267.48. Following the completion of the transaction, the chief financial officer owned 275,812 shares in the company, valued at approximately $333,732.52. The trade was a 8.06% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Hyperfine Stock Down 4.3%

NASDAQ:HYPR opened at $1.12 on Friday. The stock’s 50-day simple moving average is $1.16 and its 200 day simple moving average is $1.20. The firm has a market capitalization of $108.83 million, a PE ratio of -2.55 and a beta of 1.09. Hyperfine, Inc. has a twelve month low of $0.53 and a twelve month high of $2.22.

Hyperfine (NASDAQ:HYPR) last issued its earnings results on Wednesday, March 18th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.02. The firm had revenue of $5.29 million during the quarter, compared to the consensus estimate of $5.30 million. Hyperfine had a negative return on equity of 95.09% and a negative net margin of 262.29%. On average, analysts anticipate that Hyperfine, Inc. will post -0.57 EPS for the current fiscal year.

Institutional Trading of Hyperfine

Hedge funds have recently made changes to their positions in the company. State Street Corp grew its holdings in shares of Hyperfine by 6.1% during the fourth quarter. State Street Corp now owns 265,195 shares of the company’s stock worth $260,000 after purchasing an additional 15,200 shares during the last quarter. Sanctuary Advisors LLC boosted its position in Hyperfine by 130.9% during the 4th quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock worth $39,000 after buying an additional 22,638 shares during the period. XTX Topco Ltd grew its holdings in Hyperfine by 47.9% during the 4th quarter. XTX Topco Ltd now owns 80,735 shares of the company’s stock worth $79,000 after acquiring an additional 26,165 shares during the last quarter. Tortoise Investment Management LLC grew its holdings in Hyperfine by 60.0% during the 4th quarter. Tortoise Investment Management LLC now owns 72,000 shares of the company’s stock worth $71,000 after acquiring an additional 27,000 shares during the last quarter. Finally, EP Wealth Advisors LLC acquired a new position in Hyperfine in the 4th quarter valued at approximately $34,000. 15.03% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Zacks Research raised shares of Hyperfine to a “hold” rating in a research note on Thursday, March 19th. Lake Street Capital raised their target price on shares of Hyperfine from $2.00 to $2.50 and gave the company a “buy” rating in a research report on Thursday, March 19th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperfine in a report on Thursday, January 22nd. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Hyperfine currently has a consensus rating of “Hold” and an average target price of $1.45.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.